News

Filter

Current filters:

GeneticsLicensing

Novartis signs genome editing alliances with Intellia Therapeutics and Caribou Biosciences

Novartis signs genome editing alliances with Intellia Therapeutics and Caribou Biosciences

08-01-2015

Swiss drug major Novartis has signed collaboration and licensing agreements with Intellia Therapeutics…

GeneticsLicensingNovartisPharmaceuticalSwitzerland

NicOx appoints financial partner to assess Duchenne Muscular Dystrophy treatment

14-02-2014

French biotechnology firm NicOx (Euronext Paris: COX) has granted an undisclosed financial partner an…

BiotechnologyFranceGeneticsLicensingnaproxcinodNicOx

arGEN-X reaches two milestone payments in Shire deal and signs research agreement with Boehringer

13-01-2014

Belgium-based biotech firm arGEN-X has reached two important success milestones in its SIMPLE Antibody…

arGEN-XBelgiumBiotechnologyBoehringer IngelheimFinancialGeneticsLicensingRare diseasesResearchShire

Nuevolution signs licensing agreement with Novartis

Nuevolution signs licensing agreement with Novartis

10-01-2014

Denmark-based Nuevolution has entered into a non-exclusive technology licensing agreement with Swiss…

BiotechnologyDenmarkGeneticsLicensingNorthern EuropeNovartisNuevolutionResearch

Ethris enters SNIM modified RNA alliance with Shire

07-01-2013

German biotech firm Ethris GmbH has initiated a research based alliance focused on the development and…

BiotechnologyEthris GmbHGeneticsLicensingPharmaceuticalResearchShire

Stematix signs deal with Argentina’s Bago for stem cell therapies distribution

17-02-2010

Houston, USA-based regenerative medicines firm Stematix has entered into a 10-year exclusive agreement…

GeneticsLicensingPharmaceuticalSouth America

Back to top